{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:18:40Z","timestamp":1795036720362,"version":"4.10.2"},"reference-count":186,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>The move toward consistent and comprehensive surgical pathology reports for cancer resection specimens has been a key development in supporting evidence-based patient management and consistent cancer staging. The International Collaboration on Cancer Reporting (ICCR) previously developed a data set for reporting of the ovarian, fallopian tube and primary peritoneal carcinomas which was published in 2015. In this paper, we provide an update on this data set, as a second edition, that reflects changes in the 2020 World Health Organization (WHO) Classification of Female Genital Tumours as well as some other minor modifications. The data set has been developed by a panel of internationally recognized expert pathologists and a clinician and consists of \u201ccore\u201d and \u201cnoncore\u201d elements to be included in surgical pathology reports, with detailed commentary to guide users, including references. This data set replaces the widely used first edition, and will facilitate consistent and accurate case reporting, data collection for quality assurance and research, and allow for comparison of epidemiological and pathologic parameters between different populations.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000908","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T07:12:15Z","timestamp":1666941135000},"page":"S119-S142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-8250","authenticated-orcid":false,"given":"C. Blake","family":"Gilks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina I.","family":"Selinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Ledermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd F.","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"key":"R1-20240821","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2015.77","article-title":"Dataset for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"28","author":"McCluggage","year":"2015","journal-title":"Mod Path"},{"key":"R2-20240821","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.5858\/arpa.2016-0073-OA","article-title":"Dataset for reporting of malignant mesothelioma of the pleura or peritoneum: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20240821","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/his.13099","article-title":"Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"7","author":"Nicholson","year":"2017","journal-title":"Histopathology"},{"key":"R5-20240821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R6-20240821","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian \u201clevels of evidence\u201d","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"R9-20240821","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet"},{"key":"R10-20240821","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/AOG.0b013e3181917a0c","article-title":"Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer","volume":"113","author":"Bakkum-Gamez","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R11-20240821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PGP.0b013e3181af2372","article-title":"Prognostic factors for stage I ovarian carcinoma","volume":"29","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20240821","first-page":"263","article-title":"Prognostic factors in patients with stage I epithelial ovarian cancer","volume":"75","author":"Dembo","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R13-20240821","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1200\/JCO.1996.14.11.2968","article-title":"Natural history and prognosis of untreated stage I epithelial ovarian carcinoma","volume":"14","author":"Ahmed","year":"1996","journal-title":"J Clin Oncol"},{"key":"R14-20240821","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/AOG.0000000000003507","article-title":"Intraoperative capsule rupture, postoperative chemotherapy, and survival of women with stage I epithelial ovarian cancer","volume":"134","author":"Matsuo","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R15-20240821","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/IGC.0b013e3181991546","article-title":"Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial","volume":"19","author":"Timmers","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R16-20240821","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2011.08.036","article-title":"Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types","volume":"123","author":"Higashi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R17-20240821","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1701-2163(15)30790-8","article-title":"Endometrioid ovarian carcinoma during pregnancy presenting with acute rupture","volume":"35","author":"Gottheil","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"R18-20240821","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R19-20240821","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R20-20240821","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R21-20240821","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R22-20240821","first-page":"283A","article-title":"CCNE1 amplification may precede centrosome number abnormality in progression from serous tubal intraepithelial carcinoma to high-grade serous carcinoma","volume":"26","author":"Kuhn","year":"2013","journal-title":"Mod Pathol"},{"key":"R23-20240821","first-page":"276A","article-title":"Practical value of systematic and complete examination of fallopian tubes in unselected women undergoing salpingectomy for benign indications: results of a prospective study","volume":"26","author":"Garg","year":"2013","journal-title":"Mod Pathol"},{"key":"R24-20240821","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R25-20240821","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/his.12419","article-title":"Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal","volume":"65","author":"Singh","year":"2014","journal-title":"Histopathology"},{"key":"R26-20240821","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","article-title":"Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)","volume":"23","author":"Wethington","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R27-20240821","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R28-20240821","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000000757","article-title":"Uterine serous carcinomas frequently metastasize to the fallopian tube and can mimic serous tubal intraepithelial carcinoma","volume":"41","author":"Kommoss","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R29-20240821","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/ijgc-00009577-200601000-00006","article-title":"Sampling the omentum in ovarian neoplasia: when one block is enough","volume":"16","author":"Doig","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20240821","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.5858\/2007-131-1578-OFGCHM","article-title":"Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination?","volume":"131","author":"Usub\u00fct\u00fcn","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R31-20240821","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2004.03.004","article-title":"Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images","volume":"35","author":"Seidman","year":"2004","journal-title":"Hum Pathol"},{"key":"R32-20240821","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","article-title":"My approach to and thoughts on typing of ovarian carcinomas","volume":"61","author":"McCluggage","year":"2008","journal-title":"J Clin Pathol"},{"key":"R33-20240821","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"key":"R34-20240821","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","article-title":"Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data","volume":"23","author":"Gilks","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R35-20240821","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"27","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R36-20240821","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jcp.55.5.321","article-title":"Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?","volume":"55","author":"McCluggage","year":"2002","journal-title":"J Clin Pathol"},{"key":"R37-20240821","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/his.12386","article-title":"Review of findings in prophylactic gynaecologic specimens in Lynch syndrome with literature review and recommendations for grossing","volume":"65","author":"Downes","year":"2014","journal-title":"Histopathology"},{"key":"R38-20240821","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R39-20240821","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas","volume":"29","author":"K\u00f6bel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R40-20240821","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann Oncol"},{"key":"R41-20240821","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1158\/1078-0432.CCR-20-1268","article-title":"Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma","volume":"26","author":"Kr\u00e4mer","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R42-20240821","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000001160","article-title":"FIGO versus Silverberg grading systems in ovarian endometrioid carcinoma: a comparative prognostic analysis","volume":"43","author":"Parra-Herran","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R43-20240821","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cjp2.188","article-title":"SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma","volume":"7","author":"Tessier-Cloutier","year":"2020","journal-title":"J Pathol Clin Res"},{"key":"R44-20240821","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/1097-0142(19950101)75:1<81::AID-CNCR2820750114>3.0.CO;2-F","article-title":"The utility of the revised International Federation of Gynecology and Obstetrics histologic grading system. A Gynecologic Oncology Group Study","volume":"75","author":"Zaino","year":"1995","journal-title":"Cancer"},{"key":"R45-20240821","first-page":"119","article-title":"An analysis of two versus three grades for endometrial carcinoma","volume":"92","author":"Taylor","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R46-20240821","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0029-7844(98)00116-1","article-title":"Prognostic validity of neoplastic cells with notable nuclear atypia in endometrial cancer","volume":"92","author":"Takeshima","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R47-20240821","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/00000478-200009000-00002","article-title":"A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis","volume":"24","author":"Lax","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R48-20240821","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/cncr.20040","article-title":"Prognostic significance and interobserver variability of histologic grading system for endometrial carcinoma","volume":"100","author":"Scholten","year":"2004","journal-title":"Cancer"},{"key":"R49-20240821","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.pas.0000152129.81363.d2","article-title":"Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems","volume":"29","author":"Alkushi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R50-20240821","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up","volume":"82","author":"Shimizu","year":"1998","journal-title":"Cancer"},{"key":"R51-20240821","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000001478","article-title":"Molecular heterogeneity of endometrioid ovarian carcinoma: an analysis of 166 cases using the endometrial cancer subrogate molecular classification","volume":"44","author":"Leskela","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R52-20240821","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/his.14039","article-title":"Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systems","volume":"77","author":"Busca","year":"2020","journal-title":"Histopathology"},{"key":"R53-20240821","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PGP.0b013e318289452e","article-title":"Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases","volume":"33","author":"Khunamornpong","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R54-20240821","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/modpathol.3800366","article-title":"Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion","volume":"18","author":"Chen","year":"2005","journal-title":"Mod Pathol"},{"key":"R55-20240821","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/IGC.0000000000001202","article-title":"Characteristics and prognosis of stage I ovarian mucinous tumors according to expansile or infiltrative type","volume":"28","author":"Gouy","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R56-20240821","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.ejca.2012.12.004","article-title":"Primary invasive mucinous ovarian carcinoma of the intestinal type: importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases","volume":"49","author":"Muyldermans","year":"2013","journal-title":"Eur J Cancer"},{"key":"R57-20240821","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0000000000000564","article-title":"Ovarian endometrioid carcinoma misdiagnosed as mucinous carcinoma: an underrecognized problem","volume":"38","author":"Woodbeck","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R58-20240821","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.humpath.2004.03.005","article-title":"Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives","volume":"35","author":"Bell","year":"2004","journal-title":"Hum Pathol"},{"key":"R60-20240821","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.humpath.2004.03.006","article-title":"Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior","volume":"35","author":"Ronnett","year":"2004","journal-title":"Hum Pathol"},{"key":"R61-20240821","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.pas.0000213299.11649.fa","article-title":"Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R62-20240821","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41379-020-0618-9","article-title":"Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses","volume":"34","author":"Kang","year":"2021","journal-title":"Mod Pathol"},{"key":"R63-20240821","first-page":"2212","article-title":"Peritoneal implants of ovarian serous borderline tumors","volume":"62","author":"Bell","year":"1988","journal-title":"Histologic features and prognosis Cancer"},{"key":"R64-20240821","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R65-20240821","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R66-20240821","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/path.4293","article-title":"Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants","volume":"232","author":"Ardighieri","year":"2014","journal-title":"J Pathol"},{"key":"R67-20240821","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/PAS.0000000000001325","article-title":"Clinicopathologic and molecular features of paired cases of metachronous ovarian serous borderline tumor and subsequent serous carcinoma","volume":"43","author":"Chui","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R68-20240821","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PGP.0000000000000566","article-title":"Intratumoral heterogeneity accounts for apparent progression of noninvasive serous tumors to invasive low-grade serous carcinoma: a study of 30 low-grade serous tumors of the ovary in 18 patients with peritoneal carcinomatosis","volume":"39","author":"Seidman","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R69-20240821","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/PGP.0b013e3181c713a8","article-title":"Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications","volume":"29","author":"Carlson","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R70-20240821","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma (STIC) based on morphologic and immunohistochemical features. A reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R71-20240821","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PGP.0b013e31823b8831","article-title":"Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma","volume":"31","author":"Vang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R72-20240821","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R73-20240821","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0b013e3181934390","article-title":"Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance","volume":"28","author":"Jarboe","year":"2009","journal-title":"Int J Gynecol Pathology"},{"key":"R74-20240821","first-page":"302A","article-title":"Intramucosal growth in fallopian tube fimbriae by tumors of non-gynecologic origin may mimic serous tubal intraepithelial carcinoma and tubal mucinous metaplasia","volume":"27","author":"Rabban","year":"2014","journal-title":"Mod Pathol"},{"key":"R75-20240821","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004347-200404000-00002","article-title":"WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R76-20240821","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/IGC.0b013e3181bf8111","article-title":"Lymph node-positive stage IIIC ovarian cancer. A separate entity?","volume":"19","author":"Berek","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R77-20240821","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PGP.0b013e3182988dfd","article-title":"Stage IIIC ovarian\/ peritoneal serous carcinoma: a heterogenous group of patients with different prognosis","volume":"33","author":"Bakker","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R78-20240821","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00404-018-4675-y","article-title":"Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer","volume":"297","author":"Berretta","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R79-20240821","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1245\/s10434-014-3558-0","article-title":"Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations","volume":"21","author":"Gallotta","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R80-20240821","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/IGC.0b013e3181991a49","article-title":"Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors)","volume":"19","author":"Fadare","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R81-20240821","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/S1470-2045(11)70288-1","article-title":"Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence","volume":"13","author":"Morice","year":"2012","journal-title":"Lancet Oncol"},{"key":"R82-20240821","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.pas.0000194743.33540.e6","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R83-20240821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3181c0a5ab","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases","volume":"34","author":"Djordjevic","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R85-20240821","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"R86-20240821","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"suppl 2","key":"R88-20240821","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"143","author":"Berek","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R90-20240821","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/his.12028","article-title":"Hereditary gynaecological malignancies: advances in screening and treatment","volume":"62","author":"Folkins","year":"2013","journal-title":"Histopathology"},{"key":"R91-20240821","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"26","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"R92-20240821","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"R93-20240821","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PAS.0b013e31825d9b8d","article-title":"Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria. Identification of a BRCA1 ovarian cancer phenotype","volume":"36","author":"Fujiwara","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R94-20240821","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/cancers2010088","article-title":"Targeted therapies in epithelial ovarian cancer","volume":"2","author":"Dean","year":"2010","journal-title":"Cancers (Basel)"},{"key":"R95-20240821","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2018.10.019","article-title":"Cancer susceptibility gene mutations in type I and II endometrial cancer","volume":"152","author":"Long","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R96-20240821","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAP.0b013e3182a92cf8","article-title":"Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor type","volume":"20","author":"Chui","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R97-20240821","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/PGP.0000000000000251","article-title":"Calibration and optimization of p53, WT1, and napsin A immunohistochemistry ancillary tests for histotyping of ovarian carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) experience","volume":"35","author":"Lee","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R98-20240821","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0090-8258(90)90050-U","article-title":"Histologic sampling requirements in ovarian carcinoma: a review of 51 tumors","volume":"38","author":"Gramlich","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R99-20240821","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","article-title":"Borderline ovarian tumors: key points and workshop summary","volume":"35","author":"Silverberg","year":"2004","journal-title":"Hum Pathol"},{"key":"R100-20240821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2018.07.001","article-title":"The pathologic distinction of primary and metastatic mucinous tumors involving the ovary: a re-evaluation of algorithms based on gross features","volume":"37","author":"Hu","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"R101-20240821","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PGP.0b013e31823f844d","article-title":"Metastatic mucinous carcinomas in the ovary: a practical approach to diagnosis related to gross aspects and to immunohistochemical evaluation","volume":"31","author":"Pinto","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R102-20240821","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000478-200202000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas","volume":"26","author":"Rodr\u00edguez","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R103-20240821","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/00000478-200011000-00001","article-title":"Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with \u201cpseudomyxoma peritonei\u201d","volume":"24","author":"Lee","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R104-20240821","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/1097-0142(20001001)89:7<1541::AID-CNCR18>3.0.CO;2-9","article-title":"Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases","volume":"89","author":"Nomura","year":"2000","journal-title":"Cancer"},{"key":"R105-20240821","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pgp.0000159935.38913.57","article-title":"Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature","volume":"24","author":"Ludwick","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R106-20240821","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PGP.0b013e3181bbbcc1","article-title":"Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases","volume":"29","author":"Tabrizi","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R107-20240821","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13048-021-00783-3","article-title":"Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature","volume":"14","author":"Hada","year":"2021","journal-title":"J Ovarian Res"},{"key":"R108-20240821","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2559.2000.01015.x","article-title":"Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases","volume":"37","author":"Ariyoshi","year":"2000","journal-title":"Histopathology"},{"key":"R109-20240821","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2005.07.119","article-title":"Carcinosarcoma of the ovary-a case series","volume":"100","author":"Rutledge","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R110-20240821","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/IGC.0000000000000083","article-title":"Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: a Taiwanese Gynecologic Oncology Group Study","volume":"24","author":"Lu","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R111-20240821","first-page":"276A","article-title":"Development of a response scoring system to quantify the effect of neoadjuvant chemotherapy in ovarian cancer\u2014ovarian cancer response scoring (OCRS) study","volume":"27","author":"Boehm","year":"2014","journal-title":"Mod Pathol"},{"key":"R112-20240821","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.humpath.2006.12.008","article-title":"Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer","volume":"38","author":"Sassen","year":"2007","journal-title":"Hum Pathol"},{"key":"R113-20240821","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ygyno.2019.04.679","article-title":"Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual patient data","volume":"154","author":"Cohen","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R114-20240821","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0000000000000530","article-title":"Ovarian carcinoma histotype: strengths and limitations of integrating morphology with immunohistochemical predictions","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R115-20240821","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R116-20240821","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.pap.0000201832.15591.1d","article-title":"Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update","volume":"13","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R117-20240821","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jasc.2019.12.003","article-title":"Utility of Claudin-4 versus BerEP4 and B72.3 in pleural fluids with metastatic lung adenocarcinoma","volume":"9","author":"Patel","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"R118-20240821","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"R119-20240821","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cncy.22368","article-title":"The \u201cBrescia panel\u201d (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas","volume":"129","author":"Bernardi","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"R120-20240821","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"R121-20240821","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/modpathol.2012.200","article-title":"Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas","volume":"26","author":"Ord\u00f3\u00f1ez","year":"2013","journal-title":"Mod Pathol"},{"key":"R122-20240821","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R123-20240821","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2007.10.002","article-title":"Claudin upregulation in ovarian carcinoma effusions is associated with poor survival","volume":"39","author":"Kleinberg","year":"2008","journal-title":"Hum Pathol"},{"key":"R124-20240821","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1066896913491320","article-title":"Claudin-4 as a marker for distinguishing malignant mesothelioma from lung carcinoma and serous adenocarcinoma","volume":"21","author":"Ohta","year":"2013","journal-title":"Int J Surg Pathol"},{"key":"R125-20240821","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.pas.0000213355.72638.f4","article-title":"Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases","volume":"31","author":"Zhao","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R126-20240821","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"32","author":"Meagher","year":"2019","journal-title":"Mod Pathol"},{"key":"R127-20240821","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary","volume":"33","author":"K\u00f6bel","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R128-20240821","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.pas.0000152136.81771.12","article-title":"Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms","volume":"29","author":"Elishaev","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R129-20240821","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.pgp.0000101084.35393.03","article-title":"Utility of HPV analysis for evaluation of possible metastatic disease in women with cervical cancer","volume":"23","author":"Plaza","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R130-20240821","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PGP.0000000000000155","article-title":"Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases","volume":"34","author":"Espinosa","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R131-20240821","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PGP.0000000000000291","article-title":"Immunohistochemical profiling of endometrial serous carcinoma","volume":"36","author":"Chen","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R132-20240821","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R133-20240821","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5858\/arpa.2017-0092-OA","article-title":"Immunohistochemistry in peritoneal mesothelioma: a single-center experience of 244 cases","volume":"142","author":"Tandon","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R134-20240821","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.10.036","article-title":"Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study","volume":"72","author":"Xing","year":"2018","journal-title":"Hum Pathol"},{"key":"R135-20240821","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R136-20240821","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.pas.0000213365.56498.72","article-title":"Ovarian Sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid Sertoli-leydig cell tumors)","volume":"31","author":"McCluggage","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R137-20240821","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jcp.53.7.558","article-title":"Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms","volume":"53","author":"McCluggage","year":"2000","journal-title":"J Clin Pathol"},{"key":"R138-20240821","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2559.2002.01384.x","article-title":"Recent advances in immunohistochemistry in gynaecological pathology","volume":"46","author":"McCluggage","year":"2002","journal-title":"Histopathology"},{"key":"R139-20240821","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2005.11.002","article-title":"Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors","volume":"22","author":"McCluggage","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"R140-20240821","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0b013e31817c1b0a","article-title":"SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian Sertoli cell tumor","volume":"27","author":"Zhao","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R141-20240821","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAS.0b013e318188373d","article-title":"Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors","volume":"33","author":"Zhao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R142-20240821","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/gyno.2001.6400","article-title":"Simultaneously detected endometrial and ovarian carcinoma: a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study","volume":"83","author":"Zaino","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R143-20240821","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-2243(92)90195-5","article-title":"Synchronous primary malignancies of the female genital tract","volume":"45","author":"Ayhan","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R144-20240821","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2018.04.566","article-title":"Converging endometrial and ovarian tumorigenesis in Lynch syndrome: shared origin of synchronous carcinomas","volume":"150","author":"Niskakoski","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R145-20240821","doi-asserted-by":"crossref","first-page":"djv427","DOI":"10.1093\/jnci\/djv427","article-title":"Massively parallel sequencing-based clonality analysis of synchronous endometrioid endometrial and ovarian carcinomas","volume":"108","author":"Schultheis","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R146-20240821","doi-asserted-by":"crossref","first-page":"djv428","DOI":"10.1093\/jnci\/djv428","article-title":"Synchronous endometrial and ovarian carcinomas: evidence of clonality","volume":"108","author":"Anglesio","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"R147-20240821","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.gore.2018.12.009","article-title":"Synchronous carcinomas of endometrium and ovary: a pragmatic approach","volume":"27","author":"Blake Gilks","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R148-20240821","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-200210000-00009","article-title":"Cytokeratins 7 and 20, Dpc4 and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous carcinomas: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R149-20240821","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1097\/PAS.0b013e3181758831","article-title":"Endocervical adenocarcinomas with ovarian metastases: analysis of 29 cases with emphasis on minimally invasive cervical tumors and the ability of the metastases to simulate primary ovarian neoplasms","volume":"32","author":"Ronnett","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R150-20240821","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/pgp.0b013e318074b83f","article-title":"No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group","volume":"27","author":"Wentzensen","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R151-20240821","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R152-20240821","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R153-20240821","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R154-20240821","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms\u2019 tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R155-20240821","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"R156-20240821","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"R157-20240821","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1309\/K84K-005F-TCB8-FV4B","article-title":"WTI immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R158-20240821","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","article-title":"WT1 is expressed in serous, but not in endometrioid, clear cell or mucinous carcinoma of the peritoneum, fallopian tube, ovaries and endometrium","volume":"23","author":"Acs","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R159-20240821","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2559.2009.03390.x","article-title":"WT1, p53 and hormone receptor expression in uterine serous carcinoma","volume":"55","author":"Hirschowitz","year":"2009","journal-title":"Histopathology"},{"key":"R160-20240821","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R161-20240821","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0000000000001016","article-title":"High-grade endometrioid carcinoma of the ovary: a clinicopathologic study of 30 cases","volume":"42","author":"Assem","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R162-20240821","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R163-20240821","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/modpathol.2013.55","article-title":"The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors","volume":"26","author":"Altman","year":"2013","journal-title":"Mod Pathol"},{"key":"R164-20240821","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","article-title":"Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma","volume":"39","author":"Lim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R165-20240821","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"R166-20240821","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma","volume":"2","author":"K\u00f6bel","year":"2016","journal-title":"J Pathol Clin Res"},{"issue":"suppl 1","key":"R167-20240821","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R168-20240821","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/modpathol.2017.81","article-title":"Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups","volume":"30","author":"Parra-Herran","year":"2017","journal-title":"Mod Pathol"},{"key":"R169-20240821","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2019.09.001","article-title":"Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma","volume":"155","author":"Hollis","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R170-20240821","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/s41467-020-18819-5","article-title":"Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome","volume":"11","author":"Hollis","year":"2020","journal-title":"Nat Commun"},{"key":"R171-20240821","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/cjp2.109","article-title":"Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study","volume":"4","author":"Rambau","year":"2018","journal-title":"J Pathol Clin Res"},{"key":"R172-20240821","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol"},{"key":"R173-20240821","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/his.13772","article-title":"Nuclear \u03b2-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome","volume":"74","author":"Wang","year":"2019","journal-title":"Histopathology"},{"key":"R174-20240821","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12885-018-4242-8","article-title":"Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers","volume":"18","author":"Le Page","year":"2018","journal-title":"BMC Cancer"},{"key":"R175-20240821","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N Engl J Med"},{"key":"R176-20240821","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41588-019-0390-2","article-title":"Detecting the mutational signature of homologous recombination deficiency in clinical samples","volume":"51","author":"Gulhan","year":"2019","journal-title":"Nat Genet"},{"key":"R177-20240821","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","article-title":"Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas","volume":"69","author":"Rambau","year":"2016","journal-title":"Histopathology"},{"key":"R178-20240821","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0000000000000602","article-title":"Mismatch repair protein expression in clear cell carcinoma of the ovary: incidence and morphologic associations in 109 cases","volume":"40","author":"Bennett","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R179-20240821","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R180-20240821","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger","volume":"32","author":"Jensen","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R181-20240821","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2014.07.100","article-title":"Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary","volume":"135","author":"Vierkoetter","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R182-20240821","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/03009734.2020.1826612","article-title":"Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma","volume":"125","author":"Tholander","year":"2020","journal-title":"Ups J Med Sci"},{"key":"R183-20240821","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/s41467-019-11862-x","article-title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","volume":"10","author":"Cheasley","year":"2019","journal-title":"Nat Commun"},{"key":"R184-20240821","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1078-0432.CCR-10-1688","article-title":"Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas","volume":"17","author":"Tan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R185-20240821","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"key":"R186-20240821","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"R187-20240821","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa1909707","article-title":"Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N Engl J Med"},{"key":"R188-20240821","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N Engl J Med"},{"key":"R189-20240821","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5545","article-title":"Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities","volume":"253","author":"Cheasley","year":"2021","journal-title":"J Pathol"},{"key":"R190-20240821","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAP.0b013e31827bc24d","article-title":"Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms","volume":"20","author":"Maeda","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R191-20240821","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","article-title":"K-ras mutations in mucinous ovarian tumors","volume":"79","author":"Cuatrecasas","year":"1997","journal-title":"Cancer"},{"key":"R192-20240821","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0000000000000812","article-title":"Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary","volume":"41","author":"Rambau","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R193-20240821","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/PAS.0000000000000476","article-title":"Morphologic and molecular characteristics of mixed epithelial ovarian cancers","volume":"39","author":"Mackenzie","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:24:55Z","timestamp":1724361895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":186,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000908","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,24]]}}}